Stock 001065343 EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Edwards Lifesciences Corporation Berne S.E.

Equities

001065343

US28176E1082

Delayed Berne S.E.
Other stock markets
 12:00:02 2024-04-05 EDT 		5-day change 1st Jan Change
83.18 CHF +1.86% Intraday chart for Edwards Lifesciences Corporation -.--% +20.95%
06-20 Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing MT
06-17 Edwards Lifesciences Corporation Announces Executive Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing
MT
Edwards Lifesciences Corporation Announces Executive Changes
CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75
MT
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
BU
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus
CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM
Sector Update: Health Care Stocks Steady Premarket Monday
MT
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash
MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion
MT
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
PR
Edwards Lifesciences to Sell Critical Care to BD
BU
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.
CI
Edwards Lifesciences : Charter of the Audit Committee
PU
Some of the biggest splits in Corporate America
RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98
MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet
PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86
MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EW Stock
  4. 001065343 Stock
  5. News Edwards Lifesciences Corporation